Showing results (1761-1770 of 1,830) with videos related to

Sort By:
Pageof 183
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2020
Cytomegalovirus Coinfection Is Associated with Increased Vascular-Homing CD57+ CD4 T Cells in HIV InfectionBonnie Chen, Stephen R Morris, Soumya Panigrahi, et al.
The Journal of Clinical Investigation|October 16, 2018
Cycling CD4+ T cells in HIV-infected immune nonresponders have mitochondrial dysfunctionSouheil-Antoine Younes, Aarthi Talla, Susan Pereira Ribeiro, et al.
Frontiers in Neurology|February 7, 2025
Long-term safety of dexamethasone sodium phosphate encapsulated in autologous erythrocytes in pediatric patients with ataxia telangiectasiaMary Kay Koenig, Vincenzo Leuzzi, Riadh Gouider, et al.
Schizophrenia Bulletin|June 1, 2023
The Cost-Effectiveness of a Novel Online Social Therapy to Maintain Treatment Effects From First-Episode Psychosis Services: Results From the Horyzons Randomized Controlled TrialLidia Engel, Mario Alvarez-Jimenez, Daniela Cagliarini, et al.
The Brazilian Journal of Infectious Diseases : an Official Publication of the Brazilian Society of Infectious Diseases|November 19, 2019
A consensus document for the clinical management of invasive fungal diseases in pediatric patients with hematologic cancer and/or undergoing hematopoietic stem cell transplantation in Brazilian medical centersFabianne Carlesse, Liane Esteves Daudt, Adriana Seber, et al.
Blood|November 12, 2010
Circulating human CD4 and CD8 T cells do not have large intracellular pools of CCR5Heather A Pilch-Cooper, Scott F Sieg, Thomas J Hope, et al.
Cancer Cell|June 27, 2025
A CXCR4 partial agonist improves immunotherapy by targeting immunosuppressive neutrophils and cancer-driven granulopoiesisJin Qian, Chenkai Ma, Quin T Waterbury, et al.
Nature Communications|August 27, 2022
Limited impact of fingolimod treatment during the initial weeks of ART in SIV-infected rhesus macaquesMaria Pino, Amélie Pagliuzza, M Betina Pampena, et al.
Biorxiv : the Preprint Server for Biology|October 17, 2024
A CXCR4 partial agonist improves immunotherapy by targeting polymorphonuclear myeloid-derived suppressor cells and cancer-driven granulopoiesisJin Qian, Chenkai Ma, Quin T Waterbury, et al.
The New England Journal of Medicine|February 4, 2011
NT5E mutations and arterial calcificationsCynthia St Hilaire, Shira G Ziegler, Thomas C Markello, et al.
Pageof 183